相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Translation of Karnofsky Performance Status (KPS) for use in inpatient cancer rehabilitation
Keara M. McNair et al.
PM&R (2023)
3D or not 3D: a guide to assess cell viability in 3D cell systems
Polina Bikmulina et al.
SOFT MATTER (2022)
Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma
Swetha J. Sundar et al.
TRANSLATIONAL ONCOLOGY (2022)
Efficacy and Safety of Bevacizumab Combined with Other Therapeutic Regimens for Treatment of Recurrent Glioblastoma: A Network Meta-analysis
Su Dongpo et al.
WORLD NEUROSURGERY (2022)
Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
Michele Persico et al.
CELLS (2022)
Existing Drug Repurposing for Glioblastoma to Discover Candidate Drugs as a New a Approach
Bo Yang et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2022)
World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas A Review
Tamar R. Berger et al.
JAMA ONCOLOGY (2022)
World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas A Review
Tamar R. Berger et al.
JAMA ONCOLOGY (2022)
Current state and future perspective of drug repurposing in malignant glioma
Markus David Siegelin et al.
SEMINARS IN CANCER BIOLOGY (2021)
Improving drug response prediction by integrating multiple data sources: matrix factorization, kernel and network-based approaches
Betul Guvenc Paltun et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
Raul Ortiz et al.
CURRENT NEUROPHARMACOLOGY (2021)
Biomaterials and 3D Bioprinting Strategies to Model Glioblastoma and the Blood-Brain Barrier
Min Tang et al.
ADVANCED MATERIALS (2021)
Trends and challenges in modeling glioma using 3D human brain organoids
Aruljothi Mariappan et al.
CELL DEATH AND DIFFERENTIATION (2021)
APR-246 combined with 3-deazaneplanocin A, panobinostat or temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells
Javier de la Rosa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Mohamed E. M. Saeed et al.
INVESTIGATIONAL NEW DRUGS (2021)
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Michael Weller et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
In vitro biomimetic models for glioblastoma-a promising tool for drug response studies
Tijana Stankovic et al.
DRUG RESISTANCE UPDATES (2021)
Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR
Kedar S. Vaidya et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study
Sehar Ali et al.
PLOS ONE (2021)
Hydrogel matrix presence and composition influence drug responses of encapsulated glioblastoma spheroids
L. Hill et al.
ACTA BIOMATERIALIA (2021)
Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature
Safwan Alomari et al.
BIOMOLECULES (2021)
In Vitro Glioblastoma Models: A Journey into the Third Dimension
Mayra Paolillo et al.
CANCERS (2021)
An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma
Sean B. Lyne et al.
CANCERS (2021)
Inhibiting the Growth of 3D Brain Cancer Models with Bio-Coronated Liposomal Temozolomide
Giordano Perini et al.
PHARMACEUTICS (2021)
The optimization of combinatorial drug therapies: Strategies and laboratorial platforms
Boqian Wang et al.
DRUG DISCOVERY TODAY (2021)
Pharmacological strategies for improving the prognosis of glioblastoma
Divyaansh Raj et al.
EXPERT OPINION ON PHARMACOTHERAPY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Glioblastoma: clinical presentation, diagnosis, and management
Chris McKinnon et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Central nervous system tumors and three-dimensional cell biology: Current and future perspectives in modeling
Zaki Abou-Mrad et al.
WORLD JOURNAL OF STEM CELLS (2021)
Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing
Miodrag Dragoj et al.
BRAIN SCIENCES (2021)
Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes
Shahla Shojaei et al.
FEBS JOURNAL (2020)
Insights in the immunobiology of glioblastoma
Dimitrios Strepkos et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A. Review
Seyed H. Shahcheraghi et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics
Diana M. Leite et al.
FASEB JOURNAL (2020)
Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma
Fatima Bikhezar et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Metformin as Potential Therapy for High-Grade Glioma
Marek Mazurek et al.
CANCERS (2020)
IDH mutation in glioma: molecular mechanisms and potential therapeutic targets
Sue Han et al.
BRITISH JOURNAL OF CANCER (2020)
Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells
Roberta Azzarelli
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Management of glioblastoma: State of the art and future directions
Aaron C. Tan et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
Josep Garcia et al.
CANCER TREATMENT REVIEWS (2020)
Considering the Experimental Use of Temozolomide in Glioblastoma Research
Verena J. Herbener et al.
BIOMEDICINES (2020)
Rapid Processing and Drug Evaluation in Glioblastoma Patient-Derived Organoid Models with 4D Bioprinted Arrays
Michelle Chadwick et al.
ISCIENCE (2020)
Prevention and treatment of radiotherapy-induced side effects
Lara Barazzuol et al.
MOLECULAR ONCOLOGY (2020)
Astrocytes Decreased the Sensitivity of Glioblastoma Cells to Temozolomide and Bay 11-7082
Sadaf E. Pustchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Novel Treatment Strategies for Glioblastoma
Stanley S. Stylli
CANCERS (2020)
Treatment of patients with glioma during the COVID-19 pandemic: what we learned and what we take home for the future
Federico Pessina et al.
NEUROSURGICAL FOCUS (2020)
Temozolomide in Combination With NF-κB Inhibitor Significantly Disrupts the Glioblastoma Multiforme Spheroid Formation
Hui Xia et al.
IEEE OPEN JOURNAL OF ENGINEERING IN MEDICINE AND BIOLOGY (2020)
The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update
Mateo Ziu et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Central Nervous System Cancers Version 3.2020
Louis Burt Nabors et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Glioblastoma cancer stem cell biology: Potential theranostic targets
Farzaneh Sharifzad et al.
DRUG RESISTANCE UPDATES (2019)
A novel 3D in vitro model of glioblastoma reveals resistance to temozolomide which was potentiated by hypoxia
Ahmed Musah-Eroje et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
A Simple Three-dimensional Hydrogel Platform Enables Ex Vivo Cell Culture of Patient and PDX Tumors for Assaying Their Response to Clinically Relevant Therapies
Kolin C. Hribar et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo
Sonja Stojkovic Buric et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy
Hee-Gyeong Yi et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments
Sally L. Perrin et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Applicability of drug response metrics for cancer studies using biomaterials
Elizabeth A. Brooks et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2019)
Applying synergy metrics to combination screening data: agreements, disagreements and pitfalls
Anna H. C. Vlot et al.
DRUG DISCOVERY TODAY (2019)
Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
Hyungsin Kim et al.
CANCERS (2019)
Isobologram Analysis: A Comprehensive Review of Methodology and Current Research
Ruo-yue Huang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy. Comment on Strobel et al., Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 2019, 7, 69
Bernd Kaina
BIOMEDICINES (2019)
Induction of anaplastic lymphoma kinase (ALK) as a novel mechanism of EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models
Xiaoming Ouyang et al.
CANCER BIOLOGY & THERAPY (2018)
Repurposing drugs for glioblastoma: From bench to bedside
Joao Basso et al.
CANCER LETTERS (2018)
Role of Microenvironment in Glioma Invasion: What We Learned from In Vitro Models
Ivana Manini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
Stephen J. Bagley et al.
NEURO-ONCOLOGY (2018)
Current Challenges and Opportunities in Treating Glioblastoma
Andrea Shergalis et al.
PHARMACOLOGICAL REVIEWS (2018)
Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
Sabine Hombach-Klonisch et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma A Secondary Analysis of a Randomized Clinical Trial
Martin J. B. Taphoorn et al.
JAMA ONCOLOGY (2018)
Modeling Microenvironmental Regulation of Glioblastoma Stem Cells: A Biomaterials Perspective
John M. Heffernan et al.
FRONTIERS IN MATERIALS (2018)
Recent advances in combinatorial drug screening and synergy scoring
Tea Pemovska et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Complex bile duct network formation within liver decellularized extracellular matrix hydrogels
Phillip L. Lewis et al.
SCIENTIFIC REPORTS (2018)
Drug Screening of Human GBM Spheroids in Brain Cancer Chip
Metin Akay et al.
SCIENTIFIC REPORTS (2018)
Glioblastoma Treatments: An Account of Recent Industrial Developments
Edouard Alphandery
FRONTIERS IN PHARMACOLOGY (2018)
Statins: a new approach to combat temozolomide chemoresistance in glioblastoma
Shahla Shojaei et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2018)
Immune Checkpoints and Innovative Therapies in Glioblastoma
Massimo Romani et al.
FRONTIERS IN ONCOLOGY (2018)
Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
Bryan G. Harder et al.
FRONTIERS IN ONCOLOGY (2018)
Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins
Rosemary Yu et al.
CANCER RESEARCH (2018)
Every step of the way: integrins in cancer progression and metastasis
Hellyeh Hamidi et al.
NATURE REVIEWS CANCER (2018)
Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R
Seokmin Kang et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours
Milan T. Makale et al.
NATURE REVIEWS NEUROLOGY (2017)
A review of binimetinib for the treatment of mutant cutaneous melanoma
Peter Koelblinger et al.
FUTURE ONCOLOGY (2017)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Drug repurposing for the treatment of glioblastoma multiforme
Claudia Abbruzzese et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
P01.15 Mitochondrial poisoning as a novel therapy for glioblastoma
N. Gomez-Roman et al.
NEURO-ONCOLOGY (2017)
Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1
Alok Ranjan et al.
ONCOTARGET (2017)
Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells
Javad Alizadeh et al.
SCIENTIFIC REPORTS (2017)
Inhibitors of GLUT/SLC2A Enhance the Action of BCNU and Temozolomide against High-Grade Gliomas
Alberto Azzalin et al.
NEOPLASIA (2017)
Biomimetic Strategies for the Glioblastoma Microenvironment
Junghwa Cha et al.
FRONTIERS IN MATERIALS (2017)
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study
Martin van den Bent et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma
Russell Maxwell et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
NF-κB Signalling in Glioblastoma
Vincent Soubannier et al.
BIOMEDICINES (2017)
The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures
Ravi S. Narayan et al.
BMC CANCER (2017)
The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin-induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathways
Masanobu Tsubaki et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Penfluridol: An Antipsychotic Agent Suppresses Metastatic Tumor Growth in Triple-Negative Breast Cancer by Inhibiting Integrin Signaling Axis
Alok Ranjan et al.
CANCER RESEARCH (2016)
Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy
Kirk E. Cahill et al.
NEURO-ONCOLOGY (2016)
Targeting Notch to overcome radiation resistance
Sanaz Yahyanejad et al.
ONCOTARGET (2016)
3D modeling of human cancer: A PEG-fibrin hydrogel system to study the role of tumor microenvironment and recapitulate the in vivo effect of oncolytic adenovirus
Francesca Del Bufalo et al.
BIOMATERIALS (2016)
Heralding a new paradigm in 3D tumor modeling
Eliza L. S. Fong et al.
BIOMATERIALS (2016)
Drug repurposing for glioblastoma based on molecular subtypes
Yang Chen et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2016)
Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma
Wolfgang Wick et al.
NEURO-ONCOLOGY (2016)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2016)
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
Xiaoman Li et al.
ONCOTARGET (2016)
IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance
Amanda L. Rinkenbaugh et al.
ONCOTARGET (2016)
NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma
Sanaz Yahyanejad et al.
ONCOTARGET (2016)
ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells
Boyoung Wee et al.
SCIENTIFIC REPORTS (2016)
3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility
Xingliang Dai et al.
BIOFABRICATION (2016)
Alginate-based hydrogels with improved adhesive properties for cell encapsulation
Bapi Sarker et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2015)
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter-still a dilemma?
Monika E. Hegi et al.
NEURO-ONCOLOGY (2015)
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
L. Burt Nabors et al.
NEURO-ONCOLOGY (2015)
An image guided small animal radiation therapy platform (SmART) to monitor glioblastoma progression and therapy response
Sanaz Yahyanejad et al.
RADIOTHERAPY AND ONCOLOGY (2015)
NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells
Xuan Wang et al.
ONCOLOGY LETTERS (2015)
Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro
Eleanor Knight et al.
JOURNAL OF ANATOMY (2015)
Combined therapies of antithrombotics and antioxidants delay in silico brain tumour progression
Alicia Martinez-Gonzalez et al.
MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA (2015)
Analysis of drug combinations: current methodological landscape
Julie Foucquier et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Anti-tumor Effects of Penfluridol through Dysregulation of Cholesterol Homeostasis
Lu Wu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
Rasheena Edmondson et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2014)
Three-dimensional in vitro tumor models for cancer research and drug evaluation
Xian Xu et al.
BIOTECHNOLOGY ADVANCES (2014)
Statin use and survival following glioblastoma multiforme
David Gaist et al.
CANCER EPIDEMIOLOGY (2014)
Emerging treatment strategies for glioblastoma multiforme
Steven K. Carlsson et al.
EMBO MOLECULAR MEDICINE (2014)
A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma
Ning Yang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
Walter Taal et al.
LANCET ONCOLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease
Behzad Yeganeh et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Toward 3D Biomimetic Models to Understand the Behavior of Glioblastoma Multiforme Cells
Shreyas S. Rao et al.
TISSUE ENGINEERING PART B-REVIEWS (2014)
Coenzyme Q(10) Therapy
Juan Garrido-Maraver et al.
MOLECULAR SYNDROMOLOGY (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Tumor treating fields: a new frontier in cancer therapy
Angela M. Davies et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN USA 2012 (2013)
Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies
Sameer Agnihotri et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Krishna P. L. Bhat et al.
CANCER CELL (2013)
Prolonged Inhibition of Glioblastoma Xenograft Initiation and Clonogenic Growth following In Vivo Notch Blockade
Qian Chu et al.
CLINICAL CANCER RESEARCH (2013)
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Rakesh K. Jain
JOURNAL OF CLINICAL ONCOLOGY (2013)
Standards of care for treatment of recurrent glioblastoma-are we there yet?
Michael Weller et al.
NEURO-ONCOLOGY (2013)
Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo
Hiromichi Nakabayashi et al.
BMC CANCER (2012)
Characterization of Glioma Stem Cells Through Multiple Stem Cell Markers and Their Specific Sensitization to Double-Strand Break-Inducing Agents by Pharmacological Inhibition of Ataxia Telangiectasia Mutated Protein
Alessandro Raso et al.
BRAIN PATHOLOGY (2012)
Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation
Xiaohua Zhang et al.
CANCER SCIENCE (2012)
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Geeta Mehta et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Validation of a PicoGreen-Based DNA Quantification Integrated in an RNA Extraction Method for Two-Dimensional and Three-Dimensional Cell Cultures
Yantian Chen et al.
TISSUE ENGINEERING PART C-METHODS (2012)
Radiation Therapy for the Treatment of Recurrent Glioblastoma: An Overview
Dante Amelio et al.
Cancers (2012)
The diverse and complex roles of NF-κB subunits in cancer
Neil D. Perkins
NATURE REVIEWS CANCER (2012)
Neurosurgery for Brain Tumors: Update on Recent Technical Advances
Jonathan H. Sherman et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2011)
Frontiers in targeting glioma stem cells
Guido Frosina
EUROPEAN JOURNAL OF CANCER (2011)
Angioarchitectural heterogeneity in human glioblastoma multiforme: A fractal-based histopathological assessment
Antonio Di Ieva et al.
MICROVASCULAR RESEARCH (2011)
NF-κB addiction and its role in cancer: 'one size does not fit all'
M. M. Chaturvedi et al.
ONCOGENE (2011)
Radiobiology goes 3D: How ECM and cell morphology impact on cell survival after irradiation
Iris Eke et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Decellularized Porcine Brain Matrix for Cell Culture and Tissue Engineering Scaffolds
Jessica A. DeQuach et al.
TISSUE ENGINEERING PART A (2011)
Temozolomide: Mechanisms of Action, Repair and Resistance
Jihong Zhang et al.
Current Molecular Pharmacology (2011)
Effect of 3D-scaffold formation on differentiation and survival in human neural progenitor cells
Stefanie Ortinau et al.
BIOMEDICAL ENGINEERING ONLINE (2010)
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
Anna Martirosyan et al.
BMC CANCER (2010)
γ-Secretase Inhibitors Enhance Temozolomide Treatment of Human Gliomas by Inhibiting Neurosphere Repopulation and Xenograft Recurrence
Candace A. Gilbert et al.
CANCER RESEARCH (2010)
Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target
Erik D. Wiklund et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Intrinsic extracellular matrix properties regulate stem cell differentiation
Gwendolen C. Reilly et al.
JOURNAL OF BIOMECHANICS (2010)
The Bright and the Dark Sides of DNA Repair in Stem Cells
Guido Frosina
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Multicellular tumor spheroids: An underestimated tool is catching up again
Franziska Hirschhaeuser et al.
JOURNAL OF BIOTECHNOLOGY (2010)
Discrepancies between metabolic activity and DNA content as tool to assess cell proliferation in cancer research
Verena M. C. Quent et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
John K. Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
James R. Perry et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Angioarchitectural morphometrics of brain tumors: Are there any potential histopathological biomarkers?
Antonio Di Ieva
MICROVASCULAR RESEARCH (2010)
NOTCH Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts
Xing Fan et al.
STEM CELLS (2010)
Hydrogels as Extracellular Matrix Mimics for 3D Cell Culture
Mark W. Tibbitt et al.
BIOTECHNOLOGY AND BIOENGINEERING (2009)
Emerging role of Notch in stem cells and cancer
Zhiwei Wang et al.
CANCER LETTERS (2009)
In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016
Andrea L. Russo et al.
CLINICAL CANCER RESEARCH (2009)
Combining drugs and radiotherapy: from the bench to the bedside
Kamalakannan Palanichamy et al.
CURRENT OPINION IN NEUROLOGY (2009)
Comparative Analysis of DNA Repair in Stem and Nonstem Glioma Cell Cultures
Monica Ropolo et al.
MOLECULAR CANCER RESEARCH (2009)
DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy
Guido Frosina
MOLECULAR CANCER RESEARCH (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Promoter Methylation and Polymorphisms of the MGMT Gene in Glioblastomas: A Population-Based Study
Izabela Zawlik et al.
NEUROEPIDEMIOLOGY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Melding a New 3-Dimensional Agarose Colony Assay with the Emax Model to Determine the Effects of Drug Combinations on Cancer Cells
Yoshinori Kajiwara et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2009)
Biomaterials for stem cell differentiation
Eileen Dawson et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma
Carsten Nieder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: Systematic modulation of a synthetic cell-responsive PEG-hydrogel
Thomas P. Kraehenbuehl et al.
BIOMATERIALS (2008)
'Recurrent' glioblastoma multiforme, when should we reoperate?
Giuseppe M. V. Barbagallo et al.
BRITISH JOURNAL OF NEUROSURGERY (2008)
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Chao-Yung Wang et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Novel mechanism whereby nuclear factor κB mediates DNA damage repair through regulation of O6-methylguanine-DNA-methyltransferase
Iris Lavon et al.
CANCER RESEARCH (2007)
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma
Antje Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The effects of cell-matrix interactions on encapsulated β-cell function within hydrogels functionalized with matrix-derived adhesive peptides
Laney M. Weber et al.
BIOMATERIALS (2007)
Radiotherapy for glioblastoma in the elderly
Florence Keime-Guibert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Contribution of Notch signaling activation to human glioblastoma multiforme
Masayuki Kanamori et al.
JOURNAL OF NEUROSURGERY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma:: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
A. A. Brandes et al.
BRITISH JOURNAL OF CANCER (2006)
Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression
L Rusciani et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
RK Jain et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Statin-induced apoptosis linked with membrane farnesylated Ras small G protein depletion, rather than geranylated Rho protein
S Matzno et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2005)
Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation
BW Purow et al.
CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Epidemiology and etiology of gliomas
H Ohgaki et al.
ACTA NEUROPATHOLOGICA (2005)
In vitro and in vivo activity of the nuclear factor-κB inhibitor sulfasalazine in human glioblastomas
PA Robe et al.
CLINICAL CANCER RESEARCH (2004)
Simvastatin: a review
TR Pedersen et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells
M Werner et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial
W Roa et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Plasma concentrations of coenzyme Q10 and tocopherols in cervical intraepithelial neoplasia and cervical cancer
PR Palan et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2003)
Cost of migration: Invasion of malignant gliomas and implications for treatment
A Giese et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids
W Günther et al.
BRITISH JOURNAL OF CANCER (2003)
Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine
GP Margison et al.
MUTAGENESIS (2002)
Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels
SJ Bryant et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH (2002)
分享论文
